Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ibis Prepares Next-Gen Microorganism Detector For Diagnostic Space

This article was originally published in The Gray Sheet

Executive Summary

Five years ago the U.S. Department of Defense commissioned California-based Isis Pharmaceuticals to develop a new technology to more easily detect bioterrorism agents. Now, $55.6 million in government grants later, the company is readying the Ibis T5000 Biosensor System to make its way into the in vitro diagnostics space
Advertisement

Related Content

Abbott Grabs Ibis’ T5000 Biosensor System For Infectious Disease Diagnostics
Abbott Grabs Ibis’ T5000 Biosensor System For Infectious Disease Diagnostics
Siemens, Other Top Dx Firms Wax Molecular At AACC Lab Conference
Siemens, Other Top Dx Firms Wax Molecular At AACC Lab Conference
Advertisement
UsernamePublicRestriction

Register

MT024487

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel